Serveur d'exploration sur l'Indium - Curation (Accueil)

Index « Auteurs » - entrée « J E Westlin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J E Wagner < J E Westlin < J E de Souza Sarkis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
003070 (2004) Scintigraphic assessment of slow transit constipation with special reference to right- or left-sided colonic delay.
003B92 (2000) Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors.
003C62 (1999) [111In-DPTA-D-Phe1]-octreotide scintigraphy in the management of patients with advanced renal cell carcinoma.
003D30 (1999) Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors.
003E63 (1999) In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex.
003E64 (1999) Treatment with high dose [(111)In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors--evaluation of therapeutic and toxic effects.
003E66 (1999) Positron emission tomography and radioimmunotargeting--general aspects.
004143 (????) [111In-DTPA-D-Phe1]-octreotide scintigraphy in patients with hormone-refractory prostatic adenocarcinoma can predict therapy outcome with octreotide treatment: a pilot study.
004239 (1997) A gamma detector probe with ex vivo detection of carcinoid tumors superior to intraoperative palpation.
004240 (1997) Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy.
004845 (1995) Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.
004846 (1995) Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers.
004847 (1995) Human biodistribution of [111In]diethylenetriaminepentaacetic acid-(DTPA)-D-[Phe1]-octreotide and peroperative detection of endocrine tumors.
004B19 (1994) [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment.
005109 (1993) Distribution and elimination of the somatostatin analogue (111In-DTPA-D-Phe1)-Octreotide (OctreoScan111).
005118 (1993) Three-dimensional OctreoScan111 SPECT of abdominal manifestation of neuroendocrine tumours.
005120 (1993) Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i -k "J E Westlin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i  \
                -Sk "J E Westlin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    J E Westlin
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024